Article Details

NGM Biopharma, Merck Amend Development Pact To Focus On Retinal, Cardiovascular ...

Retrieved on: 2021-07-01 17:48:45

Tags for this article:

Click the tags to see associated articles and topics

NGM Biopharma, Merck Amend Development Pact To Focus On Retinal, Cardiovascular .... View article details on hiswai:

Excerpt

NGM Biopharmaceuticals Inc (NASDAQ: NGM) has amended and restated an agreement with Merck & Co Inc (NYSE: MRK) to extend their ongoing ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo